Medical Device Daily – VisionGate presents at OneMedForum 2012 Conference


more No Comments January 23 2012


VisionGate uses $2.6 million NIH grant to achieve full Automation of Cell-CT™ 3D imaging system for early diagnosis of cancer

VisionGate, Inc., a company developing a revolutionary non-invasive test for the early detection of lung cancer and other applications, today reported that it has achieved full automation of its Cell-CT™ system, a proprietary imaging platform that generates high-resolution 3D biosignatures from intact cells. Development of the fully automated system was funded in part by a $2.6 million grant from the National Institutes of Health’s (NIH) BRDG-SPAN program (Biomedical Research, Development, and Growth to Spur the Acceleration of New Technologies). Separately, VisionGate announced that it will be presenting at the OneMedForum 2012 Finance Conference in San Francisco on Tuesday, January 10, 2012.

More information : VG_NIH_Grant

 

 



more No Comments January 6 2012


VisionGate closes $2 million financing and announces collaboration to evaluate it’s 3D Cell Imaging platform for early lung cancer detection


more No Comments October 19 2011


The city of Phoenix, in partnership with VisionGate, Inc., is opening the world’s first biomedical 3D cellular imaging lab

The Cell-CT™ research lab, located on the Phoenix Biomedical Campus in downtown Phoenix, is seeking proposals from researchers in universities and nonprofit organizations to utilize the Cell-CT™ imaging device.


more September 10 2010


    s

    Copyright 2011 - Visiongate 3d